Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis
Guoqiang Chang, Lei Shi, Youqiong Ye, et al.
Cancer Cell (2020) Vol. 38, Iss. 6, pp. 857-871.e7
Open Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 354
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 256
The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth
Lihui Dong, Chuanyuan Chen, Yawei Zhang, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 945-957.e10
Open Access | Times Cited: 197
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation
Yuanming Cheng, Wei Xie, Brian F. Pickering, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 958-972.e8
Open Access | Times Cited: 180
The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 172
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 147
Liquid–liquid phase separation in tumor biology
Xuhui Tong, Rong Tang, Jin Xu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 135
Dynamic regulation and functions of mRNA m6A modification
Shanshan Wang, Wei Lv, Tao Li, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 127
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 121
RNA-binding proteins and cancer metastasis
Shengjie Wang, Zelong Sun, Zhe Lei, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 748-768
Closed Access | Times Cited: 96
N7-methylguanosine tRNA modification promotes tumorigenesis and chemoresistance through WNT/β-catenin pathway in nasopharyngeal carcinoma
Binbin Chen, Wei Jiang, Ying Huang, et al.
Oncogene (2022) Vol. 41, Iss. 15, pp. 2239-2253
Closed Access | Times Cited: 88
Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Qian Guan, Huiran Lin, Lei Miao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 80
YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Hengyu Chen, Yuanhang Yu, Ming Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 78
The mechanism underlying redundant functions of the YTHDF proteins
Zhongyu Zou, Caraline Sepich‐Poore, Xiaoming Zhou, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 62
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 55
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Extracellular vesicles derived from melatonin‐preconditioned mesenchymal stem cells containing USP29 repair traumatic spinal cord injury by stabilizing NRF2
Wei Liu, Pengyu Tang, Jiaxing Wang, et al.
Journal of Pineal Research (2021) Vol. 71, Iss. 4
Closed Access | Times Cited: 95
YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition
Xiangyuan Luo, Mengdie Cao, Fan Gao, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 74
Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics
Rongkai Shi, Shilong Ying, Yadan Li, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 67
Role of m6A modification in female infertility and reproductive system diseases
Jinyu Chen, Yiwei Fang, Ying Xu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3592-3604
Open Access | Times Cited: 62
YTH Domain Proteins: A Family of m6A Readers in Cancer Progression
Yirong Xu, Wei Zhang, Feng Shen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 59
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Insight into the structure, physiological function, and role in cancer of m6A readers—YTH domain-containing proteins
Jingyu Liao, Yi Wei, Junnan Liang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 58
YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis
Xuemei Yao, Wei Li, Liqi Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top